BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

730 related articles for article (PubMed ID: 27022216)

  • 41. [Inhibition of growth and metastasis of hepatocellular carcinoma by rapamycin: experiment with mice].
    Wang Z; Fan J; Zhou J; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1666-70. PubMed ID: 16854316
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic value of combined aquaporin 3 and aquaporin 5 overexpression in hepatocellular carcinoma.
    Guo X; Sun T; Yang M; Li Z; Li Z; Gao Y
    Biomed Res Int; 2013; 2013():206525. PubMed ID: 24224160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stanniocalcin-1 Reduces Tumor Size in Human Hepatocellular Carcinoma.
    Yeung BH; Shek FH; Lee NP; Wong CK
    PLoS One; 2015; 10(10):e0139977. PubMed ID: 26469082
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma.
    Ou DL; Shyue SK; Lin LI; Feng ZR; Liou JY; Fan HH; Lee BS; Hsu C; Cheng AL
    Oncotarget; 2015 Sep; 6(29):27953-65. PubMed ID: 26172295
    [TBL] [Abstract][Full Text] [Related]  

  • 45. miR-15b-5p induces endoplasmic reticulum stress and apoptosis in human hepatocellular carcinoma, both in vitro and in vivo, by suppressing Rab1A.
    Yang Y; Hou N; Wang X; Wang L; Chang S; He K; Zhao Z; Zhao X; Song T; Huang C
    Oncotarget; 2015 Jun; 6(18):16227-38. PubMed ID: 26023735
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combined inhibition of AURKA and HSF1 suppresses proliferation and promotes apoptosis in hepatocellular carcinoma by activating endoplasmic reticulum stress.
    Shen Z; Yin L; Zhou H; Ji X; Jiang C; Zhu X; He X
    Cell Oncol (Dordr); 2021 Oct; 44(5):1035-1049. PubMed ID: 34176092
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular mechanism of hepatocellular carcinoma-specific antitumor activity of the novel thienopyridine derivative TP58.
    Zhou R; Huang WJ; Guo ZY; Li L; Zeng XR; Deng YQ; Hu FY; Tong AP; Yang L; Yang JL
    Oncol Rep; 2012 Jul; 28(1):225-31. PubMed ID: 22552608
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oleic acid-induced hepatic steatosis is coupled with downregulation of aquaporin 3 and upregulation of aquaporin 9 via activation of p38 signaling.
    Gu LY; Qiu LW; Chen XF; Lü L; Mei ZC
    Horm Metab Res; 2015 Apr; 47(4):259-64. PubMed ID: 25105540
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aquaporin 3 maintains the stemness of CD133+ hepatocellular carcinoma cells by activating STAT3.
    Wang Y; Wu G; Fu X; Xu S; Wang T; Zhang Q; Yang Y
    Cell Death Dis; 2019 Jun; 10(6):465. PubMed ID: 31197130
    [TBL] [Abstract][Full Text] [Related]  

  • 50. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
    Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
    [TBL] [Abstract][Full Text] [Related]  

  • 51. AQP3 and AQP9-Contrary Players in Sepsis?
    Thon P; Rahmel T; Ziehe D; Palmowski L; Marko B; Nowak H; Wolf A; Witowski A; Orlowski J; Ellger B; Wappler F; Schwier E; Henzler D; Köhler T; Zarbock A; Ehrentraut SF; Putensen C; Frey UH; Anft M; Babel N; Sitek B; Adamzik M; Bergmann L; Unterberg M; Koos B; Rump K;
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279209
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression and modulation of Na(+) /H(+) exchanger 1 gene in hepatocellular carcinoma: A potential therapeutic target.
    Yang X; Wang D; Dong W; Song Z; Dou K
    J Gastroenterol Hepatol; 2011 Feb; 26(2):364-70. PubMed ID: 21261728
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interleukin-8 is related to poor chemotherapeutic response and tumourigenicity in hepatocellular carcinoma.
    Park SY; Han J; Kim JB; Yang MG; Kim YJ; Lim HJ; An SY; Kim JH
    Eur J Cancer; 2014 Jan; 50(2):341-50. PubMed ID: 24161763
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effects of sirolimus on the growth of transplanted hepatocellular carcinoma].
    Zhang J; Li H; Wang GS; Jiang N; Yang Y; Chen GH
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):413-6. PubMed ID: 19567017
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glo1 genetic amplification as a potential therapeutic target in hepatocellular carcinoma.
    Zhang S; Liang X; Zheng X; Huang H; Chen X; Wu K; Wang B; Ma S
    Int J Clin Exp Pathol; 2014; 7(5):2079-90. PubMed ID: 24966916
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
    Jiang H; Dong Q; Luo X; Shi B; Wang H; Gao H; Kong J; Zhang J; Li Z
    Cancer Lett; 2014 Jan; 342(1):113-20. PubMed ID: 24007863
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isomalto oligosaccharide sulfate inhibits tumor growth and metastasis of hepatocellular carcinoma in nude mice.
    Xiao CL; Tao ZH; Guo L; Li WW; Wan JL; Sun HC; Wang L; Tang ZY; Fan J; Wu WZ
    BMC Cancer; 2011 Apr; 11():150. PubMed ID: 21513518
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Euxanthone exhibits anti-proliferative and anti-invasive activities in hepatocellular carcinoma by inducing pyroptosis: preliminary results.
    Chen YF; Qi HY; Wu FL
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8186-8196. PubMed ID: 30556857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice.
    Zhang ZM; Yang XY; Deng SH; Xu W; Gao HQ
    Chin Med J (Engl); 2007 Aug; 120(15):1336-42. PubMed ID: 17711740
    [TBL] [Abstract][Full Text] [Related]  

  • 60. GdCl3 suppresses the malignant potential of hepatocellular carcinoma by inhibiting the expression of CD206 in tumor‑associated macrophages.
    Zhu F; Li X; Jiang Y; Zhu H; Zhang H; Zhang C; Zhao Y; Luo F
    Oncol Rep; 2015 Nov; 34(5):2643-55. PubMed ID: 26352004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.